NCT05664009View on ClinicalTrials.gov

The Safety and Efficacy of Redsenol-1 Plus on Cancer-related Fatigue in Adults

PHASE2RecruitingINTERVENTIONAL
Enrollment

72

Participants

Timeline

Start Date

May 30, 2023

Primary Completion Date

May 31, 2025

Study Completion Date

June 30, 2025

Conditions
FatigueCancer, Treatment-Related
Interventions
DIETARY_SUPPLEMENT

Redsenol-1 Plus

Two capsules of Redsenol-1 Plus will be taken three times per day for 12 weeks (84 days).

OTHER

Placebo

Two capsules of Placebo will be taken three times per day for 12 weeks (84 days).

Trial Locations (1)

N6B 3L1

RECRUITING

KGK Science Inc., London

Sponsors

Collaborators (1)

KGK Science Inc.
All Listed Sponsors
collaborator

KGK Science Inc.

INDUSTRY

lead

Canada Royal Enoch Phytomedicine Co., Ltd.

INDUSTRY